Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP688126.RASbPB_cXFPOU5wxR-vKQxJO8E8X81rQ6ojOh_RWu0FqU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP688126.RASbPB_cXFPOU5wxR-vKQxJO8E8X81rQ6ojOh_RWu0FqU130_assertion type Assertion NP688126.RASbPB_cXFPOU5wxR-vKQxJO8E8X81rQ6ojOh_RWu0FqU130_head.
- NP688126.RASbPB_cXFPOU5wxR-vKQxJO8E8X81rQ6ojOh_RWu0FqU130_assertion wasGeneratedBy ECO_0000203 NP688126.RASbPB_cXFPOU5wxR-vKQxJO8E8X81rQ6ojOh_RWu0FqU130_provenance.
- NP688126.RASbPB_cXFPOU5wxR-vKQxJO8E8X81rQ6ojOh_RWu0FqU130_assertion wasDerivedFrom befree-20140225 NP688126.RASbPB_cXFPOU5wxR-vKQxJO8E8X81rQ6ojOh_RWu0FqU130_provenance.
- NP688126.RASbPB_cXFPOU5wxR-vKQxJO8E8X81rQ6ojOh_RWu0FqU130_assertion SIO_000772 19527112 NP688126.RASbPB_cXFPOU5wxR-vKQxJO8E8X81rQ6ojOh_RWu0FqU130_provenance.
- NP688126.RASbPB_cXFPOU5wxR-vKQxJO8E8X81rQ6ojOh_RWu0FqU130_assertion evidence source_evidence_literature NP688126.RASbPB_cXFPOU5wxR-vKQxJO8E8X81rQ6ojOh_RWu0FqU130_provenance.
- NP688126.RASbPB_cXFPOU5wxR-vKQxJO8E8X81rQ6ojOh_RWu0FqU130_assertion description "[The aim of this study was to compare two strategies that are used to overexpress VEGF in beta-cells: (1) gene therapy through adenoviral infection and (2) a pharmacological approach using deferoxamine (DFO).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP688126.RASbPB_cXFPOU5wxR-vKQxJO8E8X81rQ6ojOh_RWu0FqU130_provenance.